Total submissions: 5
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| CHEO Genetics Diagnostic Laboratory, |
RCV000770509 | SCV000901954 | likely benign | Cardiomyopathy | 2025-04-16 | criteria provided, single submitter | clinical testing | This variant is not expected to have a clinical significance (likely benign) because it does not alter the protein sequence and it is not located within the splice consensus sequence, it is not predicted to have a significant effect on splicing, and this nucleotide is not highly conserved. This variant is listed in ClinVar (VCV000626825). This variant has an allele frequency or Grpmax Filtering Allele Frequency less than 0.03% in one or multiple control populations (gnomAD database). |
| Color Diagnostics, |
RCV000770509 | SCV001347701 | likely benign | Cardiomyopathy | 2018-11-25 | criteria provided, single submitter | clinical testing | |
| Labcorp Genetics |
RCV001410310 | SCV001612355 | likely benign | Hypertrophic cardiomyopathy 11; Dilated cardiomyopathy 1R; Atrial septal defect 5 | 2024-12-19 | criteria provided, single submitter | clinical testing | |
| Ambry Genetics | RCV002388391 | SCV002699947 | likely benign | Cardiovascular phenotype | 2022-01-30 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
| All of Us Research Program, |
RCV003999944 | SCV004844805 | likely benign | Hypertrophic cardiomyopathy | 2023-12-18 | criteria provided, single submitter | clinical testing |